541 related articles for article (PubMed ID: 29192367)
21. Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release: Implications for Sepsis-Associated Encephalopathy.
Moraes CA; Hottz ED; Dos Santos Ornellas D; Adesse D; de Azevedo CT; d'Avila JC; Zaverucha-do-Valle C; Maron-Gutierrez T; Barbosa HS; Bozza PT; Bozza FA
Mol Neurobiol; 2023 Feb; 60(2):481-494. PubMed ID: 36280654
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
23. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
24. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
25. Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury.
Cao Y; Fei D; Chen M; Sun M; Xu J; Kang K; Jiang L; Zhao M
FEBS J; 2015 Oct; 282(19):3799-807. PubMed ID: 26198480
[TBL] [Abstract][Full Text] [Related]
26. GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts.
Wang SH; Cui LG; Su XL; Komal S; Ni RC; Zang MX; Zhang LR; Han SN
Eur J Pharmacol; 2022 Apr; 920():174830. PubMed ID: 35182545
[TBL] [Abstract][Full Text] [Related]
27. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
28. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
29. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.
Chen F; Wei G; Xu J; Ma X; Wang Q
BMC Complement Altern Med; 2018 Jun; 18(1):192. PubMed ID: 29929501
[TBL] [Abstract][Full Text] [Related]
30. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced inflammasome activation in human gingival epithelial cells.
Li H; Zhou X; Zhang J
Int J Mol Med; 2014 Oct; 34(4):1039-44. PubMed ID: 25069505
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts.
Zhang A; Wang P; Ma X; Yin X; Li J; Wang H; Jiang W; Jia Q; Ni L
Mol Immunol; 2015 Aug; 66(2):253-62. PubMed ID: 25863775
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease.
Anzai F; Watanabe S; Kimura H; Kamata R; Karasawa T; Komada T; Nakamura J; Nagi-Miura N; Ohno N; Takeishi Y; Takahashi M
J Mol Cell Cardiol; 2020 Jan; 138():185-196. PubMed ID: 31836541
[TBL] [Abstract][Full Text] [Related]
34. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
35. Paeonol reduces IL-β production by inhibiting the activation of nucleotide oligomerization domain-like receptor protein-3 inflammasome and nuclear factor-κB in macrophages.
Chen G; Guo T; Yang L
Biochem Cell Biol; 2022 Feb; 100(1):28-36. PubMed ID: 34784237
[TBL] [Abstract][Full Text] [Related]
36. Naloxone inhibits nod-like receptor protein 3 inflammasome.
Lin HY; Chang YY; Kao MC; Huang CJ
J Surg Res; 2017 Nov; 219():72-77. PubMed ID: 29078913
[TBL] [Abstract][Full Text] [Related]
37. [Effects of resveratrol-mediated inhibition of NOD-like receptor protein 3 inflammasomevia activating silent information regulator 1 on the injury of intestinal mucosal barrier function after sepsis].
Gulifeire T; Yang C; Li X; Wang Y; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):535-540. PubMed ID: 34112288
[TBL] [Abstract][Full Text] [Related]
38. Non-canonical Inflammasome-Mediated IL-1β Production by Primary Endometrial Epithelial and Stromal Fibroblast Cells Is NLRP3 and Caspase-4 Dependent.
Kelly P; Meade KG; O'Farrelly C
Front Immunol; 2019; 10():102. PubMed ID: 30804935
[TBL] [Abstract][Full Text] [Related]
39. L-AP Alleviates Liver Injury in Septic Mice by Inhibiting Macrophage Activation via Suppressing NF-κB and NLRP3 Inflammasome/Caspase-1 Signal Pathways.
Liu L; Lin L; Wang Y; Yan X; Li R; He M; Li H; Zhuo C; Li L; Zhang D; Wang X; Huang W; Li X; Mao Y; Chen H; Wu S; Jiang W; Zhu L
J Agric Food Chem; 2024 Apr; 72(15):8460-8475. PubMed ID: 38564364
[TBL] [Abstract][Full Text] [Related]
40. Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome.
Liu B; Lu R; Li H; Zhou Y; Zhang P; Bai L; Chen D; Chen J; Li J; Yu P; Wu J; Liang C; Song J; Liu X; Zhou J
Phytomedicine; 2019 Jun; 59():152913. PubMed ID: 30991182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
